Prevalence of horizontal violence of nurses in their first year of practice: A systematic review

For decades, global food security has not been able to address the structural problem of economic access to food, resulting in a recent increase in the number of undernourished people from 2014. In addition, the FAO estimates that the number of undernourished people drastically increased by 82–132 million people in 2020 due to the COVID-19 pandemic. To alleviate this dramatic growth in food insecurity, it is necessary to understand the nature of the increase in the number of malnourished during the pandemic. In order to address this, we gathered and synthesized food-security-related empirical results from the first year of the pandemic in a systematic review. The vast majority (78%) of the 51 included articles reported household food insecurity has increased (access, utilization) and/or disruption to food production (availability) was a result of households having persistently low income and not having an adequate amount of savings. These households could not afford the same quality and/or quantity of food, and a demand shortfall immediately appeared on the producer side. Producers thus had to deal not only with the direct consequences of government measures (disruption in labor flow, lack of demand of the catering sector, etc.) but also with a decline in consumption from low-income households. We conclude that the factor that most negatively affects food security during the COVID-19 pandemic is the same as the deepest structural problem of global food security: low income. Therefore, we argue that there is no need for new global food security objectives, but there is a need for an even stronger emphasis on poverty reduction and raising the wages of low-income households. This structural adjustment is the most fundamental step to recover from the COVID-19 food crises, and to avoid possible future food security crises.

Download Full-text

Rapid diagnosis of COVID-19 in the first year of the pandemic: a systematic review

International Immunopharmacology ◽

10.1016/j.intimp.2021.108144 ◽

2021 ◽

pp. 108144

Author(s):

Lysandro Pinto Borges ◽

Aline Fagundes Martins ◽

Breno de Mello Silva ◽

Bruna de Paula Dias ◽

Ricardo Lemes Gonçalves ◽

...

Keyword(s):

Systematic Review ◽

Rapid Diagnosis ◽

First Year

Download Full-text

Complementary feeding and micronutrient status: a systematic review

American Journal of Clinical Nutrition ◽

10.1093/ajcn/nqy266 ◽

2019 ◽

Vol 109 (Supplement_1) ◽

pp. 852S-871S ◽

Cited By ~ 13

Author(s):

Julie E Obbagy ◽

Laural K English ◽

Tricia L Psota ◽

Yat Ping Wong ◽

Nancy F Butte ◽

...

Keyword(s):

Systematic Review ◽

Fatty Acid ◽

Iron Status ◽

First Year ◽

Vitamin B ◽

Fatty Acid Status ◽

Micronutrient Status ◽

Acid Status ◽

Vitamin B 12 ◽

Fortified Cereal

ABSTRACTBackgroundProper nutrition during early life is critical for growth and development.ObjectivesThe aim was to describe systematic reviews conducted by the Nutrition Evidence Systematic Review team for the USDA and the Department of Health and Human Services Pregnancy and Birth to 24 Months Project to answer the following: What is the relation between 1) timing of introduction of complementary foods and beverages (CFBs) or 2) types and/or amounts of CFBs consumed and micronutrient status (iron, zinc, vitamin D, vitamin B-12, folate, and fatty acid status)?MethodsA literature search identified articles from developed countries published from January 1980 to July 2016 that met the inclusion criteria. Data were extracted and risk of bias assessed. Evidence was qualitatively synthesized to develop a conclusion statement, and the strength of the evidence was graded.ResultsNine articles addressed the timing of CFB introduction and 31 addressed types or amounts or both of CFBs. Moderate evidence suggests that introducing CFBs at age 4 mo instead of 6 mo offers no advantages or disadvantages in iron status among healthy full-term infants. Evidence is insufficient on the timing of CFB introduction and other micronutrient status outcomes. Strong evidence suggests that CFBs containing iron (e.g., meat, fortified cereal) help maintain adequate iron status or prevent deficiency in the first year among infants at risk of insufficient iron stores or low intake. Benefits for infants with sufficient iron stores (e.g., infant formula consumers) are less clear. Moderate evidence suggests that CFBs containing zinc (e.g., meat, fortified cereal) support zinc status in the first year and CFB fatty acid composition influences fatty acid status. Evidence is insufficient with regard to types and amounts of CFBs and vitamin D, vitamin B-12, and folate status, or the relation between lower-iron-containing CFBs and micronutrient status.ConclusionsSeveral conclusions on CFBs and micronutrient status were drawn from these systematic reviews, but more research that addresses specific gaps and limitations is needed.

Download Full-text

Effect of Bisphosphonates on Bone Health in Adult Renal Transplant Patients: Beyond the First Year Posttransplant—A Systematic Review and Meta-Analysis

Canadian Journal of Kidney Health and Disease ◽

10.1177/2054358119858014 ◽

2019 ◽

Vol 6 ◽

pp. 205435811985801 ◽

Cited By ~ 1

Author(s):

Alyssa Lip ◽

Ashley Warias ◽

M. Khaled Shamseddin ◽

Benjamin Thomson ◽

D. Thiwanka Wijeratne

Keyword(s):

Systematic Review ◽

Lumbar Spine ◽

Renal Transplant ◽

Bone Health ◽

Observational Studies ◽

Meta Analysis ◽

First Year ◽

Bisphosphonate Treatment ◽

Mineral Density

Background: Bone mineral density (BMD) decreases postrenal transplantation. Evidence demonstrating the effects of bisphosphonates on BMD and fracture risk beyond 1-year posttransplant is sparse in existing literature, but remains essential to enhance clinical outcomes in this population. Objective: Our study aimed to systematically review and meta-analyze the current literature on the use of any bisphosphonate in the adult renal transplant population beyond the first year of renal transplant to determine its effect on BMD and fracture incidence. Design: We conducted a systematic review and meta-analysis of primary research literature that included full-text, English-language, original randomized clinical trials (RCTs) and observational studies. Setting: Patient data were primarily captured in an outpatient setting across various studies. Patients: Our population of interest was patients older than 18 years who received deceased/living donor kidney transplantation and any bisphosphonate with a follow-up greater than 12 months posttransplantation. Measurements: The primary outcome was change in BMD from baseline. Secondary outcomes were the incidence of fractures and effects of other confounders on bone health. Methods: We included RCTs and observational studies that satisfied our inclusion criteria. Each study was analyzed for risk of bias and data were extrapolated to analyze for overall statistical significance accounting for heterogeneity of studies. Results: Sixteen studies (N = 1762) were analyzed. The follow-up ranged from 12 to 98 months. There was a nonsignificant improvement in BMD with bisphosphonate treatment persisting into the second and third years posttransplant at the lumbar spine. The calculated standardized mean BMD difference was −0.29 (−0.75 to 0.17), P = .22. Only 5 studies reported a total of 43 new fractures. Prednisone ( P < .01), low body weight ( P < .001), low body mass index ( P < .01), and male gender ( P < .05) correlated with reduced lumbar and femoral BMD. Limitations: Limitations of this review include the use of BMD as a surrogate outcome, the bias of the included studies, and the incomplete reporting data in numerous analyzed studies. Conclusions: We demonstrate no statistically significant benefit of bisphosphonate treatment on BMD beyond the first year postrenal transplantation. Despite heterogeneity of treatment, a differential nonsignificant improvement in lumbar spine BMD was consistent and may be clinically relevant. Trial Registration: PROSPERO CRD42019125593

Download Full-text

Antibiotic prophylaxis for prevention of urinary tract infections in the first year of life in children with vesicoureteral reflux diagnosed in the workup of antenatal hydronephrosis: a systematic review

Pediatric Nephrology ◽

10.1007/s00467-020-04568-6 ◽

2020 ◽

Vol 35 (9) ◽

pp. 1639-1646

Author(s):

Jennifer Leigh ◽

Mandy Rickard ◽

Stephanie Sanger ◽

Joanne Petropoulos ◽

Luis H. Braga ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Antibiotic Prophylaxis ◽

Vesicoureteral Reflux ◽

Urinary Tract Infections ◽

First Year ◽

Antenatal Hydronephrosis ◽

Tract Infections ◽

First Year Of Life

Download Full-text

A comprehensive systematic review on lateral/horizontal violence in the profession of nursing

JBI Library of Systematic Reviews ◽

10.11124/jbisrir-2012-172 ◽

2012 ◽

Vol 10 (Suppl) ◽

pp. 1-17 ◽

Cited By ~ 2

Author(s):

Leslie Rittenmeyer ◽

Dolores Huffman ◽

Michelle Block ◽

Kathleen Kleefisch ◽

Maureen Marthaler ◽

...

Keyword(s):

Systematic Review ◽

Horizontal Violence

Download Full-text

The neurobiology of suicide in psychosis: A systematic review

Journal of Psychopharmacology ◽

10.1177/0269881120936919 ◽

2020 ◽

Vol 34 (8) ◽

pp. 811-819 ◽

Cited By ~ 1

Author(s):

Ragy R Girgis

Keyword(s):

Systematic Review ◽

High Risk ◽

General Population ◽

Lifetime Risk ◽

First Year ◽

Positive Symptoms ◽

Clinical High Risk ◽

Severe Problem ◽

Work Done ◽

The Relationship

The lifetime risk of dying by suicide in schizophrenia and related psychoses has been estimated to be approximately between 5% and 7%, though some have estimated that the number is closer to 10%. The highest risk for suicide occurs within the first year after presentation, when patients have a 12 times greater risk of dying by suicide than the general population, or a 60% higher risk compared with patients in other phases of psychosis, although the risk continues for many years. Some 31% of all deaths in first and early episode samples are due to suicide. Studies in individuals at clinical high-risk for psychosis (CHR) or with attenuated positive symptoms also demonstrate that suicidality is common and problematic in these individuals. Therefore, suicide in psychosis is a particularly severe problem. In order to develop interventions aimed at reducing the risk of suicide in psychotic individuals, it will be critical to understand the neurobiology of suicide in psychosis. In this paper, I report on the results of a systematic review of the work done to date on the neurobiology of suicide in psychosis and on suicidality in the CHR period. I will also identify gaps in knowledge and discuss future strategies for studying the neurobiology of suicidality in psychosis that may help to disentangle the links between suicide and psychosis and, by doing so, allow us to gain a greater understanding of the relationship between suicide and psychosis, which is critical for developing interventions aimed at reducing the risk of suicide in psychotic individuals.

Download Full-text